Clinical Trial Update: Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR [NA]

View source ↗

Summary

A completed clinical trial evaluated detection of clinically significant prostate cancer using 18F-DCFPyL PET/MR.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-DCFPyL (DCFPyL radiotracer for PSMA imaging)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Neoplasm, Prostate | NA | Status: COMPLETED